SuperworthPACS price to book ratio PACS
Market value divided by the book value of the company's net assets, since 2024.
- Today, Oct 23, 2026
- 6.8×
- 2-year median
- 5.6×
- Against its 2-year history
- 72nd
- percentile: 0 is its lowest day, 100 its highest
- 2-year range
- 2.4× to 42.1×
- Peer median
- 4.7×
PACS' price to book ratio is 6.8× as of Oct 23, 2026.
That is above its 2-year median of 5.6×, higher than on 72% of days in the last 2 years.
Over that time it ranged from 2.4× in Apr 2025 to 42.1× in Aug 2024.
The median for 10 hospital and care facility stocks of a similar size is 4.7×.
Price to book ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 6.8× | 5.1× | 7.4× |
| 2025 | 6.9× | 2.4× | 6.9× |
| 2024 | 3.5× | 3.5× | 42.1× |
Against its peers
Companies in Medical - Care Facilities nearest PACS' size, closest first, today.
| Company | Price to book ratio |
|---|---|
| PACSPACS | 6.8× |
| CHEChemed | 8.1× |
| ENSGEnsign | 4.2× |
| UHSUniversal Health Services | 1.5× |
| SHCSotera Health | 7.8× |
| CONConcentra Group Holdings Parent | 10.5× |
| LFSTLifeStance Health | 3.3× |
| DVADavita | n/m |
| BTSGBrightSpring Health Services | 5.8× |
| OPCHOption Care Health | 3.7× |
| EHCEncompass Health | 4.7× |
| Peer median | 4.7× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on PACS
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.